Novo Holdings led the financing round to support portfolio expansion and international growth.
"Through its impressive track record to date, Exscientia has demonstrated the value of combining deep scientific expertise with cutting-edge technology capabilities to significantly accelerate drug discovery. Novo Holdings’ investment underscores our interest in supporting technology companies that enable life science research and innovation, and our commitment to this area. We see significant opportunity for the company to further grow its participation in the drug discovery ecosystem and are excited to work with the Exscientia team in realising this vision."
— Robert Ghenchev, Managing Partner of Growth Investments
The seed round was co-led by Playfair Capital and Credo Ventures with participation from Techstart Ventures and angel investors.
"Before founding Continuum Industries, we led a 150-people strong hyperloop team at the University of Edinburgh. While there, we built the UK’s first hyperloop prototype vehicle and successfully competed in contests run by SpaceX and Virgin Hyperloop One. It was the hyperloop moonshot that made us realise the socio-economic value of infrastructure and forced us to think about better ways of taking infrastructure projects from ideas to reality."
The London startup secured backing from Pentech and Speedinvest to drive the development of its neural image compression software.
"As humans, our eyes have evolved to care about certain colours and properties of the natural world. It helped us survive as hunters and gathers. We are more sensitive to the colour green as it represents fertile areas with food and water; we notice the slightest of movements in still scenes, as this helps us flee from sneaking predators."
